EMBO Molecular MedicineNeurosciencePeer-reviewed journal article
Protective anti-prion antibodies in human immunoglobulin repertoires
Assunta SenatoreiD, Karl FrontzekiD, Marc EmmeneggeriD, Andra ChincisaniD, Marco LosaiD, Regina ReimanniD, Geraldine Horny, Jingjing GuoiD, Sylvie FelsiD, Silvia SorceiD, Caihong ZhuiD, Nathalie GeorgeiD, Stefan EwertiD, Thomas PietzonkaiD, Simone HornemanniD, Adriano AguzziiD
Abstract
Prion immunotherapy may hold great potential, but antibodies against certain PrP epitopes can be neurotoxic. Here we identified >6000 PrP-binding antibodies in a synthetic human Fab phage display library, 49 of which we characterized in detail. Antibodies directed against the flexible tail of PrP conferred neuroprotection against infectious prions. We then mined published repertoires of circulating B cells from healthy humans and found antibodies similar to the protective phage-derived antibodies. When expressed recombinantly, these antibodies exhibited anti-PrP reactivity. Furthermore, we surveyed 48718 samples from 37894 hospital patients for the presence of anti-PrP IgGs, and found 21 high-titer individuals. The clinical files of these individuals did not reveal any enrichment of specific pathologies, suggesting that anti-PrP autoimmunity is innocuous. The existence of protective anti-prion antibodies in unbiased human immunological repertoires, combined with the reported lack of such antibodies in carriers of disease-associated PRNP mutations, suggests a link to the low incidence of spontaneous prion diseases in human populations.
- Citations
- 24
- FWCI
- 1.46
- Field percentile
- top 19%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A bispecific immunotweezer prevents soluble PrP oligomers and abolishes prion toxicity
Marco Bardelli, Karl Frontzek, … Luca Varani·PLoS PathogensPeer-reviewed·Oct 1, 2018
- Ligands binding to the cellular prion protein induce its protective proteolytic release with therapeutic potential in neurodegenerative proteinopathies
Luise Linsenmeier, Behnam Mohammadi, … Markus Glatzel·Science AdvancesPeer-reviewed·Nov 24, 2021
- Cleavage site-directed antibodies reveal the prion protein in humans is shed by ADAM10 at Y226 and associates with misfolded protein deposits in neurodegenerative diseases
Feizhi Song, Valerija Kovač, … Hermann C. Altmeppen·Acta NeuropathologicaPeer-reviewed·Jul 9, 2024
- Leveraging the dominant-negative effect of the kuru-protective G127Vprion protein variant as a novel therapeutic strategy
Jean R.P. Gatdula, Nadia A. Mirza-Romero, … David A. Harris·Neurobiology of DiseasePeer-reviewed·Jun 29, 2026
- PRNP mutations initially generate an alternatively misfolded PrP species that dissuades prion replication
Genki Amano, Hamza Arshad, … Joel C. Watts·bioRxiv·Sep 28, 2026
- Aβ, tau, α-synuclein, huntingtin, TDP-43, PrP and AA are members of the innate immune system: a unifying hypothesis on the etiology of AD, PD, HD, ALS, CJD and RSA as innate immunity disorders
Claudiu I. Bandea·bioRxiv·Nov 18, 2013